May aid in the diagnosis of prion disease. RT-QuIC identifies the disease-causing agent. Total TAU and 14-3-3γ are indirect markers of neurodegenerative diseases. Assumes that the patient has a ...

Fujirebio is launching a human cerebrospinal fluid (CSF) assay in its continuing efforts to detect Alzheimer’s ...

Tauopathies are a group of neurodegenerative diseases associated with aggregated tau proteins. These diseases typically progress over the years, and their symptoms are linked to neurological ...

OTTAWA, Ontario — Looking for Alzheimer’s disease (AD) biomarkers in plasma instead of cerebrospinal fluid (CSF) is a simpler form of screening individuals for AD pathology and could result in earlier ...

MTBR-tau243 — microtubule-binding region of tau containing the residue 243 — is a specific blood biomarker of tau tangle pathology in patients with Alzheimer's disease (AD), new research shows.

Etalanetug demonstrated reduction of eMTBR-tau243, a novel CSF and plasma biomarker that specifically reflects tau tangle pathology, in Phase Ib/II study TOKYO, Dec. 1, 2025 /PRNewswire/ -- Eisai Co., ...

The findings from the study indicate that higher genetic risk score for Alzheimer disease (AD) are associated with cognitive declines in patients with Parkinson disease (PD), while higher genetic risk ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--axialHealthcare, a national leader in pain management and pain medication solutions, today announced it has successfully completed a System and Organization Controls ...

TOKYO, Dec 2, 2025 - (JCN Newswire) - - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) today announced that new data on anti-tau antibody etalanetug (development code: E2814) was presented at ...